Cerenome, Inc. (CNSY) vs Tvardi Therapeutics, Inc. (TVRD)

Cerenome, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Cerenome, Inc. and Tvardi Therapeutics, Inc. are of similar size ($14.7M and $14.3M). Cerenome, Inc. grew revenue faster over the last twelve months: −21.0% against −34.4%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −526.5%) and the higher return on invested capital (0.00% vs −532.8%). Across the 16 metrics below, Tvardi Therapeutics, Inc. leads on 10 and Cerenome, Inc. on 6.

Valuation

Metric CNSY TVRD Biotechnology median
P/E n/m n/m 7.88
P/S 3.27 1.07 11.47
P/B 2.51 1.42 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.89 2.42 10.73
Earnings yield (168.84%) (219.69%) (28.84%)
Free cash flow yield (175.55%) (236.42%) (23.03%)

Profitability

Metric CNSY TVRD Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (628.12%) 0.00% 0.00%
Net margin (526.48%) 0.00% 0.00%
Free cash flow margin (560.29%) 0.00% 0.00%
Return on equity (520.84%) (126.19%) (57.72%)
Return on assets (181.53%) (85.08%) (49.22%)
Return on invested capital (532.77%) 0.00% 0.00%

Growth

Metric CNSY TVRD Biotechnology median
Revenue growth (TTM) (20.95%) (34.36%) 5.64%
EPS growth (last fiscal year) 82.79% 79.51% —
Revenue growth, 5-year CAGR (5.72%) (18.53%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSY TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.37 1.87 4.73
Net debt to EBITDA 0.83 1.15 0.96

Dividend

Metric CNSY TVRD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CNSY TVRD Biotechnology median
Market cap 14.26m 14.67m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack